What is the #$%$ problem that Amgen doesn't start the bidding war and offers 1 AMGN for 3 KERX. The #$%$ game is over. All data sets from the US and Japan are identical despite completely different ethnicities, enrollment centers, principle investigators, statisticians etc. Just let me know what the #$%$ problem is so I can solve it.
BP is not going to take on unnecessary risk without approvals first. Why would they?? They could get two big ones within 2014. Of course with approval they will pay more which is to the share holders benefit.